Research Daily
Today's Must Read
Strategic Efforts Sustain Facebook's (FB) Momentum
Caterpillar (CAT) Sales Down for 42 Months
Portfolio Strength, Cost Actions Supporting DuPont (DD)
Today's must-read reports are for Facebook (FB), DuPont (DD) and Caterpillar (CAT).
Facebook shares continue to stand out, with the strong earnings power of its franchise getting duly acknowledged. The stock currently has a Zacks Rank #1 (Strong Buy), but the analyst sees the momenum sustaining itself even in the long run given the company's still-growing user base and the monetization potential of Instagram, Oculus, Messenger and WhatsApp. (See the full reserach report on Facebook here)
Completion of DuPont's merger with Dow Chemicals is still some ways off, but the analyst likes the company's strong product portfolio and new product launches. The analyst highlights DuPont's strong balance sheet and committment to shareholder returns. This Zacks Rank #2 (Buy) stock is in the process of a $2 billion share buy-back program and currently pays a 2.26% yielding dividend. (You can see the research report on DuPont here)
Caterpillar shares appear to have finally found a footing after a very long period of losing ground. The uptick in commodity prices has helped improve sentiment, with the stock up almost +12% in the year-to-date period. This favorable momentum notwithstanding, the company is still faced with major headwinds in its business, particulalrly on the mining side. The analyst discusses the pros & cons of investing in Caterpillar at present in the research report. (See the full research report on Caterpillar here)
Other noteworthy reports today include GlaxoSmithKline (GSK), Pepsi (PEP) and Intel (INTC).
- Here is the research report for Glaxo (GSK)
- Here is the research report for Pepsi (PEP)
- Here is the research report for Intel (INTC)
Sheraz Mian
Director of Research
Get the latest research report on INTC - FREE
Get the latest research report on GSK - FREE
Get the latest research report on CAT - FREE
Get the latest research report on DD - FREE
Get the latest research report on PEP - FREE